NA Vaccine Institute Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Employees
  • 18

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 10

NA Vaccine Institute General Information

Description

Developer of vaccine adjuvants and immune boosters designed to offer potentiated vaccines for global immunization. The company researches cancer therapeutic vaccines, cancer immunotherapy, infectious diseases, peptide vaccines for chronic metabolic disorders, allergy, and stroke therapy, enabling healthcare providers with adjuvant-infused needle-free and cold chain-free nasal vaccines.

Contact Information

Website
www.navaccine.org
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 904, SKV1 Building A, 128 Beobwon-ro
  • Songpa-gu
  • Seoul, 05854
  • South Korea
+82
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • 904, SKV1 Building A, 128 Beobwon-ro
  • Songpa-gu
  • Seoul, 05854
  • South Korea
+82

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

NA Vaccine Institute Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Secondary Transaction - Private Completed Pre-Clinical Trials
4. Early Stage VC (Series B) 18-Nov-2021 Completed Pre-Clinical Trials
3. Early Stage VC (Series A) 23-Apr-2019 Completed Pre-Clinical Trials
2. Accelerator/Incubator 31-May-2018 Completed Startup
1. Seed Round 01-Jan-2018 Completed Startup
To view NA Vaccine Institute’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

NA Vaccine Institute Patents

  • 25

    Total Documents Applications and Grants

  • Total Patents Families

  • 10

    Granted

  • 10

    Pending

  • Expiring in next 12 mo

NA Vaccine Institute Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20260117272-A1 Large-scale production method of double-stranded rna Pending 25-Oct-2024
EP-4684796-A1 Influenza vaccine composition for pulmonary delivery Pending 23-Mar-2023
EP-4684796-A4 Influenza vaccine composition for pulmonary delivery Pending 23-Mar-2023
US-20260335426-A1 Influenza vaccine composition for pulmonary delivery Pending 23-Mar-2023
WO-2024195963-A1 Influenza vaccine composition for pulmonary delivery Inactive 23-Mar-2023 A61K39/12
To view NA Vaccine Institute’s complete patent history, request access »

NA Vaccine Institute Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

NA Vaccine Institute Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds
BIONOTE Corporation Minority
DS Asset Management Asset Manager Minority
DSC Investment Venture Capital Minority
IMM Investment Asset Manager Minority
Industrial Bank of Korea PE/Buyout Minority
You’re viewing 5 of 10 investors. Get the full list »

Ready to get started?

Request a free trial

NA Vaccine Institute FAQs

  • When was NA Vaccine Institute founded?

    NA Vaccine Institute was founded in 2018.

  • Where is NA Vaccine Institute headquartered?

    NA Vaccine Institute is headquartered in Seoul, South Korea.

  • What is the size of NA Vaccine Institute?

    NA Vaccine Institute has 18 total employees.

  • What industry is NA Vaccine Institute in?

    NA Vaccine Institute’s primary industry is Drug Discovery.

  • Is NA Vaccine Institute a private or public company?

    NA Vaccine Institute is a Private company.

  • What is NA Vaccine Institute’s current revenue?

    The current revenue for NA Vaccine Institute is .

  • How much funding has NA Vaccine Institute raised over time?

    NA Vaccine Institute has raised $20.2M.

  • Who are NA Vaccine Institute’s investors?

    BIONOTE, DS Asset Management, DSC Investment, IMM Investment, and Industrial Bank of Korea are 5 of 10 investors who have invested in NA Vaccine Institute.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process